These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 1534442)

  • 1. Cardiovascular risk factors in chronic renal failure and hemodialysis populations.
    Ma KW; Greene EL; Raij L
    Am J Kidney Dis; 1992 Jun; 19(6):505-13. PubMed ID: 1534442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hypertension before beginning dialysis on survival of hemodialysis patients.
    Lucas MF; Quereda C; Teruel JL; Orte L; Marcén R; Ortuño J
    Am J Kidney Dis; 2003 Apr; 41(4):814-21. PubMed ID: 12666068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease.
    McCullough PA; Chan CT; Weinhandl ED; Burkart JM; Bakris GL
    Am J Kidney Dis; 2016 Nov; 68(5S1):S5-S14. PubMed ID: 27772643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of interleukin-6 -174G/C promoter polymorphism with hypertension and left ventricular hypertrophy in dialysis patients.
    Losito A; Kalidas K; Santoni S; Jeffery S
    Kidney Int; 2003 Aug; 64(2):616-22. PubMed ID: 12846758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardioprotection: an essential component for predialysis chronic renal failure treatment].
    Jungers P; Qualim Z; Nguyen-Khoa T; Massy Z; London G
    Nephrologie; 2003; 24(2):79-88. PubMed ID: 12723513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A; Naderi AS
    Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of cardiovascular death in ESRD.
    Zoccali C; Tripepi G; Mallamaci F
    Semin Nephrol; 2005 Nov; 25(6):358-62. PubMed ID: 16298255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease in patients with chronic kidney disease.
    Jaradat MI; Molitoris BA
    Semin Nephrol; 2002 Nov; 22(6):459-73. PubMed ID: 12430090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease.
    Fragoso A; Mendes F; Silva AP; Neves PL
    J Diabetes Complications; 2015; 29(8):1098-104. PubMed ID: 26066409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular abnormalities and hypertension in the elderly dialysis patient.
    Dikow R; Zeier M; Ritz E
    Semin Dial; 2002; 15(2):121-6. PubMed ID: 11952940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for cardiovascular disease in children on maintenance dialysis.
    Chavers B; Schnaper HW
    Adv Ren Replace Ther; 2001 Jul; 8(3):180-90. PubMed ID: 11533919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular disease in chronic renal failure: pathophysiologic aspects.
    London GM
    Semin Dial; 2003; 16(2):85-94. PubMed ID: 12641870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of cardiovascular disease in chronic renal disease.
    Foley RN; Parfrey PS; Sarnak MJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S16-23. PubMed ID: 11443763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein Subfractions, Uric Acid and Cardiovascular Risk in End-Stage Renal Disease (ESRD) Patients.
    Gluba-Brzozka A; Franczyk B; Bartnicki P; Rysz-Gorzyn Ska M; Rysz J
    Curr Vasc Pharmacol; 2017; 15(2):123-134. PubMed ID: 27774887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients.
    Sit D; Kadiroglu AK; Yilmaz ME; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):403-7. PubMed ID: 16060127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of 24-hour ambulatory blood pressure monitoring and of night/day ratio in nondiabetic, cardiovascular events-free hemodialysis patients.
    Tripepi G; Fagugli RM; Dattolo P; Parlongo G; Mallamaci F; Buoncristiani U; Zoccali C
    Kidney Int; 2005 Sep; 68(3):1294-302. PubMed ID: 16105064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reappraisal in two European cohorts of the prognostic power of left ventricular mass index in chronic kidney failure.
    Tripepi G; Pannier B; D'Arrigo G; Mallamaci F; Zoccali C; London G
    Kidney Int; 2017 Mar; 91(3):704-710. PubMed ID: 28010886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lipid-lowering therapy on reduction of cardiovascular events in patients with end-stage renal disease requiring hemodialysis.
    Marrs JC; Saseen JJ
    Pharmacotherapy; 2010 Aug; 30(8):823-9. PubMed ID: 20653359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiovascular disease in Chinese chronic renal insufficiency patients-epidemiology survey].
    Hou FF; Ma ZG; Mei CL; Rong S; Huang SM; Liu XR; Yuan WJ; Guo YS; Wang L; He Q; Wang XL; Sang XH; Li XL
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):458-63. PubMed ID: 15854551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of vascular disease in renal failure.
    Ikizler TA
    Blood Purif; 2002; 20(1):6-10. PubMed ID: 11803153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.